Abramson Cancer Center of the University of Pennsylvania at Perelman Center for Advanced Medicine is a clinical research site located in Philadelphia, Pennsylvania, United States.
Crixeo Health Trust Score: 61/100 (FAIR). This profile has not yet been claimed by the site owner.
Abramson Cancer Center of the University of Pennsylvania at Perelman Center for Advanced Medicine has participated in 3 clinical trials.
Therapeutic areas: Multiple Myeloma, Carcinoma, Non-Small-Cell Lung, Prostate Cancer.
Sponsors: Amgen, Pfizer.
Trust Score: 61/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Abramson Cancer Center of the University of Pennsylvania at Perelman Center for Advanced Medicine has a Crixeo Trust Score of 61/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Abramson Cancer Center of the University of Pennsylvania at Perelman Center for Advanced Medicine has 3 clinical trials on record. Their work covers Multiple Myeloma, Carcinoma, Non-Small-Cell Lung, Prostate Cancer.
Abramson Cancer Center of the University of Pennsylvania at Perelman Center for Advanced Medicine has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.